Cargando…

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management

Ketamine is a versatile medication with an emerging role for the treatment of numerous psychiatric conditions, including treatment resistant depression. Current psychiatry guidelines for its intravenous administration to treat depression recommend regular blood pressure monitoring and an aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yip, Ryan, Swainson, Jennifer, Khullar, Atul, McIntyre, Roger S., Skoblenick, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556663/ https://www.ncbi.nlm.nih.gov/pubmed/36245888 http://dx.doi.org/10.3389/fpsyt.2022.1017504

Ejemplares similares

A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
por: Chubbs, Brittany, et al.
Publicado: (2022)

Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
por: Swainson, Jennifer, et al.
Publicado: (2022)

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
por: Zhou, Yanling, et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
por: Elkrief, Laurent, et al.
Publicado: (2022)

Down and High: Reflections Regarding Depression and Cannabis
por: Langlois, Catherine, et al.
Publicado: (2021)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
por: Matveychuk, Dmitriy, et al.
Publicado: (2020)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

Controversies of the Effect of Ketamine on Cognition
por: Zhang, Melvyn W. B., et al.
Publicado: (2016)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis
por: Ma, Haijing, et al.
Publicado: (2022)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder
por: Han, Han, et al.
Publicado: (2021)

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
por: Muscat, Sherry-Anne, et al.
Publicado: (2021)

Prevalence of depression, anxiety and post-traumatic stress in war- and conflict-afflicted areas: A meta-analysis
por: Lim, Isis Claire Z. Y., et al.
Publicado: (2022)

Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women
por: Gagne, Collin, et al.
Publicado: (2022)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
por: Garel, Nicolas, et al.
Publicado: (2023)

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
por: Zuckerman, Hannah, et al.
Publicado: (2018)

The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis
por: Fan, Mingyue, et al.
Publicado: (2021)

Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder
por: Wang, Peng-Wei, et al.
Publicado: (2021)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study
por: Gutierrez, Gilmar, et al.
Publicado: (2022)

Practical pathway for the management of depression in the workplace: a Canadian perspective
por: Chokka, Pratap, et al.
Publicado: (2023)

A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
por: Mikellides, Georgios, et al.
Publicado: (2022)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
por: Hassan, Kazi, et al.
Publicado: (2022)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uimkiskc7jqnoj36975bjnnelm